NO942758L - Benzopyraner og beslektede LTB4 antagonister - Google Patents

Benzopyraner og beslektede LTB4 antagonister

Info

Publication number
NO942758L
NO942758L NO942758A NO942758A NO942758L NO 942758 L NO942758 L NO 942758L NO 942758 A NO942758 A NO 942758A NO 942758 A NO942758 A NO 942758A NO 942758 L NO942758 L NO 942758L
Authority
NO
Norway
Prior art keywords
benzopyrans
ltb4 antagonists
antagonists
substituted
formula
Prior art date
Application number
NO942758A
Other languages
English (en)
Norwegian (no)
Other versions
NO942758D0 (no
Inventor
Kevin Koch
Jr Lawrence S Melvin
Lawrence Alan Reiter
Sally G Ruggeri
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO942758L publication Critical patent/NO942758L/no
Publication of NO942758D0 publication Critical patent/NO942758D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/08Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C07C255/13Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
NO942758A 1992-01-23 1994-07-22 Benzopyraner og beslektede LTB4 antagonister NO942758D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82467892A 1992-01-23 1992-01-23
US89005592A 1992-05-28 1992-05-28
PCT/US1992/008555 WO1993015066A1 (fr) 1992-01-23 1992-10-13 Benzopyranne et antagonistes du ltb4 apparentes

Publications (2)

Publication Number Publication Date
NO942758L true NO942758L (no) 1994-07-22
NO942758D0 NO942758D0 (no) 1994-07-22

Family

ID=27124835

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942758A NO942758D0 (no) 1992-01-23 1994-07-22 Benzopyraner og beslektede LTB4 antagonister

Country Status (27)

Country Link
US (1) US5550152A (fr)
EP (1) EP0623122B1 (fr)
JP (1) JP2813464B2 (fr)
KR (1) KR950700274A (fr)
CN (1) CN1074681A (fr)
AP (1) AP385A (fr)
AT (1) ATE149493T1 (fr)
AU (1) AU2773392A (fr)
BG (1) BG98873A (fr)
BR (1) BR9207064A (fr)
CA (1) CA2117349C (fr)
CZ (1) CZ395492A3 (fr)
DE (1) DE69217998T2 (fr)
DK (1) DK0623122T3 (fr)
ES (1) ES2098547T3 (fr)
FI (1) FI943473A (fr)
GR (1) GR3022999T3 (fr)
HU (1) HUT67929A (fr)
IL (1) IL104421A0 (fr)
IS (1) IS3968A (fr)
MX (1) MX9300313A (fr)
NO (1) NO942758D0 (fr)
OA (1) OA10713A (fr)
PT (1) PT101182A (fr)
TW (1) TW213456B (fr)
UY (1) UY23537A1 (fr)
WO (1) WO1993015066A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
CA2202056A1 (fr) * 1994-10-13 1996-04-25 Mark A. Dombroski Composes de benzopyranne et composes benzo-fusionnes, leur preparation et leur utilisation comme antagonistes du leucotriene b4' (ltb4)
MX9702731A (es) * 1994-10-13 1997-06-28 Pfizer Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos.
SK31399A3 (en) * 1996-09-16 2000-05-16 Pfizer Processes and intermediates for preparing substituted chromanol derivatives
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
EP0836850A3 (fr) * 1996-10-17 2000-11-29 Pfizer Inc. Méthode pour prévenir le rejet d'allogreffes
EP0963755A3 (fr) * 1998-04-16 2001-03-14 Pfizer Products Inc. Utilisation des benzopyranes pour la prévention de rejets de graiffes
JP2004512382A (ja) 2000-11-03 2004-04-22 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー 心臓灌流および心臓炎症の2核種同時イメージング
US6958156B2 (en) * 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
US6541613B2 (en) * 2000-12-15 2003-04-01 Uyrex Corporation Isoflavone derivatives
CA2433516A1 (fr) * 2001-01-30 2002-08-08 Keith Michael Devries Procedes de preparation d'acides chromanylbenzoiques
CA2574627A1 (fr) * 2004-07-22 2006-02-02 Pharmacia Corporation Compositions pour le traitement anti-inflammatoire et anti-douleur au moyen d'une combinaison d'un inhibiteur selectif cox-2 et d'un antagoniste recepteur de ltb<sb>4</sb>
KR101107800B1 (ko) * 2006-10-31 2012-01-25 화이자 프로덕츠 인코포레이티드 무기질코르티코이드 수용체 길항제로서의 피라졸린 화합물
CN104710438B (zh) * 2013-12-11 2019-11-29 中国科学院上海药物研究所 促进iPS细胞产生的螺环类化合物及其制备方法和用途
JP6590224B2 (ja) * 2014-11-11 2019-10-16 学校法人順天堂 加齢黄斑変性症予防又は治療剤
WO2017040963A1 (fr) 2015-09-03 2017-03-09 Forma Therapeutics, Inc. Inhibiteurs de hdac8 bicyclique [6,6] fusionnée
US20190382363A1 (en) 2015-11-30 2019-12-19 Merck Sharp & Dohme Corp. Aryl sulfonamides as blt1 antagonists
US10336733B2 (en) 2015-11-30 2019-07-02 Merk Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
US10450309B2 (en) 2015-11-30 2019-10-22 Merch Sharp & Dohme Corp. Aryl sulfonamides as BLT1 antagonists
EP3383389B1 (fr) 2015-11-30 2021-04-28 Merck Sharp & Dohme Corp. Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1
CN109289091B (zh) * 2018-10-09 2021-04-13 温州医科大学附属第一医院 一种用于装载骨髓间充质干细胞的复合支架及其制备方法
CN111647003B (zh) * 2020-06-08 2022-06-21 中国科学院昆明植物研究所 三环氧六氢色酮a及其药物组合物和其应用
CN111671745A (zh) * 2020-07-29 2020-09-18 北京大学 化合物在治疗溃疡性结肠炎药物制备中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (fr) * 1987-01-12 1993-07-20 Darrel M. Gapinski Agents antiinflammatoires
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
WO1990015801A1 (fr) * 1989-06-22 1990-12-27 Pfizer Inc. Sulfamides substitues et composes apparentes dans le traitement de l'asthme, de l'arthrite et des maladies apparentees

Also Published As

Publication number Publication date
IL104421A0 (en) 1993-05-13
HUT67929A (en) 1995-05-29
ES2098547T3 (es) 1997-05-01
US5550152A (en) 1996-08-27
AP9200441A0 (en) 1993-01-31
MX9300313A (es) 1994-06-30
OA10713A (en) 2002-12-04
FI943473A0 (fi) 1994-07-22
FI943473A (fi) 1994-07-22
CN1074681A (zh) 1993-07-28
IS3968A (is) 1993-07-24
CA2117349A1 (fr) 1993-08-05
TW213456B (fr) 1993-09-21
UY23537A1 (es) 1993-06-28
DE69217998D1 (de) 1997-04-10
ATE149493T1 (de) 1997-03-15
CA2117349C (fr) 2000-02-29
AU2773392A (en) 1993-09-01
BR9207064A (pt) 1995-12-19
WO1993015066A1 (fr) 1993-08-05
JPH07503464A (ja) 1995-04-13
AP385A (en) 1995-05-15
HU9402163D0 (en) 1994-09-28
KR950700274A (ko) 1995-01-16
JP2813464B2 (ja) 1998-10-22
GR3022999T3 (en) 1997-07-30
CZ395492A3 (en) 1994-03-16
DE69217998T2 (de) 1997-06-12
EP0623122A1 (fr) 1994-11-09
BG98873A (en) 1995-03-31
EP0623122B1 (fr) 1997-03-05
NO942758D0 (no) 1994-07-22
DK0623122T3 (da) 1997-04-21
PT101182A (pt) 1994-03-31

Similar Documents

Publication Publication Date Title
NO942758L (no) Benzopyraner og beslektede LTB4 antagonister
ATE116973T1 (de) Substituierte thiazole und ihre anwendung als fungizide.
DE69736642D1 (de) Heterocyclische Verbindungen, ihre Herstellung und Verwendung
BR9002976A (pt) Composto heterociclico condensado,processo para preparar o mesmo,composicao fungicida e composto de acido carboxilico heterociclico condensado
ATE120193T1 (de) Zellwachstum hemmende makrozyklische lactone namens combretastatin d-2.
DE68904792D1 (de) Biozide zusammensetzung.
ES2078356T3 (es) Derivados de la pirrolidina y de la piperidina.
CA2037975A1 (fr) Analogues du 5-hydroxy-2,3-dihydrobenzofurane comme inhibiteurs de la biosynthese des leucotrienes
DK0597423T3 (da) Azetidinonforbindelse og fremgangsmåde til fremstilling deraf
CA2226406A1 (fr) Nouveaux derives de l&#39;acide pyridonecarboxylique
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
DE69319859D1 (de) Neue tetracyclische verbindungen
WO2002059089A3 (fr) Procede de preparation d&#39;analogues d&#39;indene heterocycliques
UY23285A1 (es) Biocidas industriales, su uso y su preparacion
ATE88471T1 (de) Azolylmethylcyloalkyloxirane, ihre herstellung und verwendung als pflanzenschutzmittel.
EP0516860A4 (en) Chromone derivative and aldose reductase inhibitor containing the same as active ingredient
NZ220160A (en) Pyridyl cyclopropane carboxamides and fungicidal compositions
DE68916685D1 (de) Mevalonolactone vom Typ Pyrazolopyridin.
CA2052020A1 (fr) Derives de la pradimicine
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
JPS5319392A (en) Polyamino cyclic polysaccharide compounds and their preparation
TH8348EX (th) สารผสมสำหรับซักล้างชนิดอ่อนซึ่งมีอัลคิลไกลโคไซด์เป็นองค์ประกอบหลัก ยังประกอบด้วยเทอร์พีนและอนุพันธ์ของไอโซไธอาโซโลน
TH14988EX (th) &#34; สไปโรไซโคลอัลคิล-ซับสทิทิวเต็ดอะเซ็ททิดิโนนที่ใช้ประโยชน์ได้เป็นสารลดโคเรสเตอรอล &#34;
TH13639A (th) เบนโซไพรานและแอนทาโกนิสของ ltb4 ที่สัมพันธ์กัน